Access and closure of the left ventricular apex: State of play

Journal of Thoracic Disease

Volumn 7, Issue 9, 2015, Pages 1548-1555

  Ziegelmueller, Johannes Amadeus ^a   Lange, Rüdiger ^a   Bleiziffer, Sabine ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apical closure devices; Transcatheter aortic valve implantation (TAVI)

Indexed keywords

ANTEGRADE TRANSAPICAL; AORTA VALVE; APICAL CLOSURE; APICAL CLOSURE DEVICE; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGICAL EQUIPMENT; EQUIPMENT DESIGN; HEART SURGERY; HEMOSTASIS; HUMAN; MEDICAL DECISION MAKING; MITRAL VALVE; PATIENT SAFETY; PRODUCT DEVELOPMENT; RETROGRADE TRANSFEMORAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURGICAL APPROACH; SUTURE; TRANSAPICAL ACCESS DEVICE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; WOUND CLOSURE;

EID: 84947436917     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.09.11     Document Type: Review

References (26)

1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
2. Leon MB, Smith CR, Mack M, et al. Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
3. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790-8.
4. Bleiziffer S, Krane M, Deutsch MA, et al. Which way in? The necessity of multiple approaches to transcatheter valve therapy. Curr Cardiol Rev 2013;9:268-73.
5. Shults C, Gunter R, Thourani VH. The versatility of transapical access: Will it lead to a completely new approach to valvular therapy? Ann Cardiothorac Surg 2012;1:220-3.
6. Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;8:129-38.
7. Bleiziffer S, Ruge H, Mazzitelli D, et al. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg 2009;138:1073-80.
8. Ye J, Cheung A, Lichtenstein SV, et al. Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg 2006;131:1194-6.
9. Généreux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 2012;60:1043-52.
10. Walther T, Thielmann M, Kempfert J, et al. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II). Eur J Cardiothorac Surg 2012;42:278-83; discussion 283.
11. Dewey TM, Bowers B, Thourani VH, et al. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg 2013;96:2083-9.
12. Wendler O, Walther T, Schroefel H, et al. Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. Eur J Cardiothorac Surg 2013;43:505-11; discussion 511-2.
13. Pitta SR, Cabalka AK, Rihal CS. Complications associated with left ventricular puncture. Catheter Cardiovasc Interv 2010;76:993-7.
14. Bleiziffer S, Piazza N, Mazzitelli D, et al. Apical-accessrelated complications associated with trans-catheter aortic valve implantation. Eur J Cardiothorac Surg 2011;40:469-74.
15. Généreux P, Cohen DJ, Williams MR, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014;63:1100-9.
16. Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation: step by step. Ann Thorac Surg 2009;87:276-83.
17. Thomas M, Schymik G, Walther T, et al. Oneyear outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
18. Kempfert J, Treede H, Rastan AJ, et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur J Cardiothorac Surg 2013;43:52-6; discussion 57.
19. Wong DR, Ye J, Cheung A, et al. Technical considerations to avoid pitfalls during transapical aortic valve implantation. J Thorac Cardiovasc Surg 2010;140:196-202.
20. Sipahi NF, Papadopoulos N, Moritz A, et al. Linear Closure of the Left Ventricular Apex Following Transcatheter-Based Aortic Valve Implantation. Thorac Cardiovasc Surg 2015;63:508-9.
21. Tang GH, Lansman SL, Cohen M, et al. Transcatheter aortic valve replacement: current developments, ongoing issues, future outlook. Cardiol Rev 2013;21:55-76.
22. Knight PA, Sauer JS, Kaufer JW, et al. Automated remote transapical wound closure system study. Ann Thorac Surg 2011;92:1494-8.
23. Blumenstein J, Van Linden A, Arsalan M, et al. Experimental evaluation of a new apical access and closure device. Ann Thorac Surg 2012;94:1706-9.
24. Blumenstein J, Kempfert J, Van Linden A, et al. First-inman evaluation of the transapical APICA ASC access and closure device: the initial 10 patients. Eur J Cardiothorac Surg 2013;44:1057-62; discussion 1062.
25. Conradi L, Seiffert M, Shimamura K, et al. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation. Thorac Cardiovasc Surg 2014;62:498-502.
26. Brinks H, Nietlispach F, Göber V, et al. Transapical access closure: the TA PLUG device. Interact Cardiovasc Thorac Surg 2013;17:806-9; discussion 809-10.